In vitro characterization of trophic factor expression in neural precursor cells

Stem Cells and Development

Volumn 21, Issue 3, 2012, Pages 432-447

  Hawryluk, Gregory W J ^a,b,c   Mothe, Andrea J ^a   Chamankhah, Mahmood ^a   Wang, Jian ^a   Tator, Charles ^a,b,c   Fehlings, Michael G ^a,b,c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; PLATELET DERIVED GROWTH FACTOR A; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BRAIN CELL; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; FIBROBLAST; IN VITRO STUDY; MICROENVIRONMENT; MOUSE; MULTIVARIATE ANALYSIS; NERVE CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RNA ISOLATION; SPINAL CORD; STATISTICAL ANALYSIS; STEM CELL; STROMA CELL;

ANIMALS; BONE MARROW CELLS; BRAIN; CELL DIFFERENTIATION; CULTURE MEDIA; FEEDER CELLS; FIBROBLASTS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, TRANSGENIC; NERVE GROWTH FACTORS; NEURAL STEM CELLS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RNA; SPINAL CORD; STROMAL CELLS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 84863063465     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0242     Document Type: Article

References (86)

1. Hawryluk GW and MG Fehlings. (2009). Cellular transplantation approaches for repair of the injured spinal cord: ongoing and pending clinical trials. Top SCI Rehabil 14:47-61.
2. Hawryluk GW and MG Fehlings. (2008). The center of the spinal cord may be central to its repair. Cell Stem Cell 3:230-232.
3. Svendsen CN, MA Caldwell and T Ostenfeld. (1999). Human neural stem cells: isolation, expansion and transplantation. Brain Pathol 9:499-513. (Pubitemid 29316290)
4. Svendsen CN and MA Caldwell. (2000). Neural stem cells in the developing central nervous system: implications for cell therapy through transplantation. Prog Brain Res 127:13-34. (Pubitemid 35461254)
5. Karimi-Abdolrezaee S, E Eftekharpour, J Wang, CM Morshead and MG Fehlings. (2006). Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci 26:3377-3389.
6. Hawryluk GW, A Mothe, J Wang, S Wang, CH Tator andMG Fehlings. An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev [Epub ahead of print]; DOI: 10.1089/scd.2011.0596.
7. Tetzlaff W, EB Okon, S Karimi-Abdolrezaee, CE Hill, JS Sparling, JR Plemel, WT Plunet, EC Tsai, D Baptiste, et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 28:1611-1682.
8. Parr AM, CH Tator and A Keating. (2007). Bone marrowderived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 40:609-619. (Pubitemid 47456475)
9. Rossi SL and HS Keirstead. (2009). Stem cells and spinal cord regeneration. Curr Opin Biotechnol 20:552-562.
10. Enzmann GU, RL Benton, JF Talbott, Q Cao and SR Whittemore. (2006). Functional considerations of stem cell transplantation therapy for spinal cord repair. J Neurotrauma 23:479-495.
11. Chen J, Y Li, M Katakowski, X Chen, L Wang, D Lu, M Lu, SC Gautam and M Chopp. (2003). Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73:778-786. (Pubitemid 37071731)
12. Widenfalk J, K Lundströmer, M Jubran, S Brene and L Olson. (2001). Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J Neurosci 21:3457-3475. (Pubitemid 32422810)
13. Koda M, M Murakami, H Ino, K Yoshinaga, O Ikeda, M Hashimoto, M Yamazaki, C Nakayama and H Moriya. (2002). Brain-derived neurotrophic factor suppresses delayed apoptosis of oligodendrocytes after spinal cord injury in rats. J Neurotrauma 19:777-785. (Pubitemid 34761339)
14. Neuhuber B, B Timothy Himes, JS Shumsky, G Gallo and I Fischer. (2005). Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 1035:73-85. (Pubitemid 40248539)
15. Tolwani RJ, JM Cosgaya, S Varma, R Jacob, LE Kuo and Shooter EM. (2004). BDNF overexpression produces a longterm increase in myelin formation in the peripheral nervous system. J Neurosci Res. 77:662-669. (Pubitemid 39194607)
16. Hempstead BL and JL Salzer. (2002). A glial spin on neurotrophins. Science. 298:1184-1186.
17. Nakamura M, H Okano, Y Toyama, HN Dai, TP Finn and BS Bregman. (2005). Transplantation of embryonic spinal cordderived neurospheres support growth of supraspinal projections and functional recovery after spinal cord injury in the neonatal rat. J Neurosci Res 81:457-468. (Pubitemid 41297383)
18. Chen Q, L Zhou and HD Shine. (2006). Expression of neurotrophin-3 promotes axonal plasticity in the acute but not chronic injured spinal cord. J Neurotrauma 23:1254-1260. (Pubitemid 44681480)
19. Wright KT, W El Masri, A Osman, J Chowdhury and WE Johnson. (2011). Bone marrow for the treatment of spinal cord injury: mechanisms and clinical application. Stem Cells 29:169-178.
20. Rossi SL, G Nistor, T Wyatt, HZ Yin, AJ Poole, JH Weiss, MJ Gardener, S Dijkstra, DF Fischer and HS Keirstead. Histological and functional benefit following transplantation of motor neuron progenitors to the injured rat spinal cord. PLoS One 5:e11852.
21. Sharp J, J Frame, M Siegenthaler, G Nistor and HS Keirstead. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 28:152-163.
22. Ruff CA and MG Fehlings. Neural stem cells in regenerative medicine: bridging the gap. Panminerva Med 52:125-147.
23. Sykova E, P Jendelova, L Urdzikova, P Lesny and A Hejcl. (2006). Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair. Cell Mol Neurobiol 26:1113-1129. (Pubitemid 44924034)
24. Pearse DD and MB Bunge. (2006). Designing cell-and genebased regeneration strategies to repair the injured spinal cord. J Neurotrauma 23:438-452. (Pubitemid 43726320)
25. Du Y and CF Dreyfus. (2002). Oligodendrocytes as providers of growth factors. J Neurosci Res 68:647-654. (Pubitemid 34594982)
26. Tropepe V, M Sibilia, BG Ciruna, J Rossant, EF Wagner and D van der Kooy. (1999). Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev Biol 208:166-188. (Pubitemid 29149456)
27. Hakamata Y, K Tahara, H Uchida, Y Sakuma, M Nakamura, A Kume, T Murakami, M Takahashi, R Takahashi, et al. (2001). Green fluorescent protein-transgenic rat: a tool for organ transplantation research. Biochem Biophys Res Commun 286:779-785. (Pubitemid 32912955)
28. Mothe AJ and CH Tator. (2008). Transplanted neural stem/ progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination. Exp Neurol 213:176-190.
29. Parr AM, I Kulbatski, T Zahir, X Wang, C Yue, A Keating and CH Tator. (2008). Transplanted adult spinal cord-derived neural stem/progenitor cells promote early functional recovery after rat spinal cord injury. Neuroscience 155:760-770.
30. Clark BR, C Jamieson and A Keating. (1997). Human longterm bone marrow culture. Methods Mol Biol 75:249-256.
31. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
32. Bodnar MS, JJ Meneses, RT Rodriguez and MT Firpo. (2004). Propagation and maintenance of undifferentiated human embryonic stem cells. Stem Cells Dev 13:243-253. (Pubitemid 38738366)
33. Hogan B, R Beddington, F Constantini and E Lacy. (1994). Manipulating the Mouse Embryo: A Laboratory Manual Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
34. Wilkins A, S Chandran and A Compston. (2001). A role for oligodendrocyte-derived IGF-1 in trophic support of cortical neurons. Glia 36:48-57.
35. Giehl KM, A Schutte, P Mestres and Q Yan. (1998). The survival-promoting effect of glial cell line-derived neurotrophic factor on axotomized corticospinal neurons in vivo is mediated by an endogenous brain-derived neurotrophic factor mechanism. J Neurosci 18:7351-7360. (Pubitemid 28425819)
36. Deleyrolle L, S Marchal-Victorion, C Dromard, V Fritz, M Saunier, JC Sabourin, C Tran Van Ba, A Privat and JP Hugnot. (2006). Exogenous and fibroblast growth factor 2/ epidermal growth factor-regulated endogenous cytokines regulate neural precursor cell growth and differentiation. Stem Cells 24:748-762. (Pubitemid 44464780)
37. Magy L, C Mertens, V Avellana-Adalid, M Keita, F Lachapelle, B Nait-Oumesmar, B Fontaine and A Baron-Van Evercooren. (2003). Inducible expression of FGF2 by a rat oligodendrocyte precursor cell line promotes CNS myelination in vitro. Exp Neurol 184:912-922. (Pubitemid 38182819)
38. Albrecht PJ, JC Murtie, JK Ness, JM Redwine, JR Enterline, RC Armstrong and SW Levison. (2003). Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production. Neurobiol Dis 13:89-101. (Pubitemid 36793975)
39. Blesch A, HS Uy, RJ Grill, JG Cheng, PH Patterson and MH Tuszynski. (1999). Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury. J Neurosci 19:3556-3566. (Pubitemid 29203135)
40. Zai LJ, S Yoo and JR Wrathall. (2005). Increased growth factor expression and cell proliferation after contusive spinal cord injury. Brain Res 1052:147-155. (Pubitemid 41116772)
41. Fressinaud C. (2005). Repeated injuries dramatically affect cells of the oligodendrocyte lineage: effects of PDGF and NT-3 in vitro. Glia 49:555-566. (Pubitemid 40353840)
42. Lu P, LL Jones, EY Snyder and MH Tuszynski. (2003). Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181:115-129. (Pubitemid 36629234)
43. Mothe AJ, I Kulbatski, A Parr, M Mohareb and CH Tator. (2008).Adult spinal cord stem/progenitor cells transplanted as neurospheres preferentially differentiate into oligodendrocytes in the adult rat spinal cord. Cell Transplant 17:735-751.
44. Bozkurt G, AJ Mothe, T Zahir, H Kim, MS Shoichet and CH Tator. Chitosan channels containing spinal cord-derived stem/progenitor cells for repair of subacute spinal cord injury in the rat. Neurosurgery 67:1733-1744.
45. Eftekharpour E, S Karimi-Abdolrezaee, J Wang, H El Beheiry, C Morshead, MG Fehlings. (2007). Myelination of congenitally dysmyelinated spinal cord axons by adult neural precursor cells results in formation of nodes of Ranvier and improved axonal conduction. J Neurosci 27:3416-3428. (Pubitemid 46515125)
46. Karimi-Abdolrezaee S, E Eftekharpour, J Wang, D Schut and MG Fehlings. Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J Neurosci 30:1657-1676.
47. Neuhuber B, B Timothy Himes, JS Shumsky, G Gallo and I Fischer. (2005). Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 1035:73-85. (Pubitemid 40248539)
48. Smith R, V Bagga and RA Fricker-Gates. (2003). Embryonic neural progenitor cells: the effects of species, region, and culture conditions on long-term proliferation and neuronal differentiation. J Hematother Stem Cell Res 12:713-725. (Pubitemid 38101560)
49. Novikova LN, S Lobov, M Wiberg and LN Novikov. Efficacy of olfactory ensheathing cells to support regeneration after spinal cord injury is influenced by method of culture preparation. Exp Neurol 229:132-142.
50. LladóJ, C Haenggeli, NJ Maragakis, EY Snyder and Rothstein JD. (2004). Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci 27:322-331. (Pubitemid 39433844)
51. Kamei N, N Tanaka, Y Oishi, T Hamasaki, K Nakanishi, N Sakai and M Ochi. (2007). BDNF, NT-3, and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organotypic cocultures. Spine (Phila Pa 1976) 32:1272-1278. (Pubitemid 46791444)
52. Zhang YW, J Denham, RS Thies. (2006). Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. Stem Cells Dev 15:943-952. (Pubitemid 46147864)
53. Einstein O, N Grigoriadis, R Mizrachi-Kol, E Reinhartz, E Polyzoidou, I Lavon, I Milonas, D Karussis, O Abramsky and T Ben-Hur. (2006). Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp Neurol 198:275-284.
54. Kerr BJ and PH Patterson. (2004). Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse. Exp Neurol 188:391-407. (Pubitemid 38891600)
55. Sendtner M, R Gotz, B Holtmann, JL Escary, Y Masu, P Carroll, E Wolf, G Brem, P Brulet and H Thoenen. (1996). Cryptic physiological trophic support of motoneurons by LIF revealed by double gene targeting of CNTF and LIF. Curr Biol 6:686-694. (Pubitemid 126656336)
56. Hughes RA, M Sendtner and H Thoenen. (1993). Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J Neurosci Res 36:663-671. (Pubitemid 24002991)
57. Vartanian T, Y Li, M Zhao and K Stefansson. (1995). Interferon-gamma- induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1:732-743. (Pubitemid 3013083)
58. Azari MF, C Profyris, T Karnezis, CC Bernard, DH Small, SS Cheema, E Ozturk, I Hatzinisiriou and S Petratos. (2006). Leukemia inhibitory factor arrests oligodendrocyte death and demyelination in spinal cord injury. J Neuropathol Exp Neurol 65:914-929. (Pubitemid 44371237)
59. Kerr BJ and PH Patterson. (2005). Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury. Glia 51:73-79. (Pubitemid 41059160)
60. Bugga L, RA Gadient, K Kwan, CL Stewart and PH Patterson. (1998). Analysis of neuronal and glial phenotypes in brains of mice deficient in leukemia inhibitory factor. J Neurobiol 36:509-524. (Pubitemid 28402557)
61. Kahn MA and J De Vellis. (1994). Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines. Glia 12:87-98. (Pubitemid 2153354)
62. Mayer M, K Bhakoo and M Noble. (1994). Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120:143-153. (Pubitemid 24031196)
63. Nakamura M, RA Houghtling, L MacArthur, BM Bayer and BS Bregman. (2003). Differences in cytokine gene expression profile between acute and secondary injury in adult rat spinal cord. Exp Neurol 184:313-325. (Pubitemid 37444041)
64. Hamada Y, T Ikata, S Katoh, K Katoh, M Niwa, Y Tsutsumishita and K Fukuzawa. (1996). Effects of exogenous transforming growth factor-beta 1 on spinal cord injury in rats. Neurosci Lett 203:97-100. (Pubitemid 26043085)
65. Prehn JH, C Backhauss and J Krieglstein. (1993). Transforming growth factor-beta 1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J Cereb Blood Flow Metab 13:521-525. (Pubitemid 23129406)
66. Nakano N, Y Nakai, TB Seo, Y Yamada, T Ohno, A Yamanaka, Y Nagai, M Fukushima, Y Suzuki, T Nakatani and C Ide. Characterization of conditioned medium of cultured bone marrow stromal cells. Neurosci Lett 483: 57-61.
67. Chen Q, Y Long, X Yuan, L Zou, J Sun, S Chen, JR Perez-Polo and K Yang. (2005). Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J Neurosci Res 80:611-619. (Pubitemid 40896182)
68. Yaghoobi MM and SJ Mowla. (2006). Differential gene expression pattern of neurotrophins and their receptors during neuronal differentiation of rat bone marrow stromal cells. Neurosci Lett 397:149-154. (Pubitemid 43340477)
69. Prowse AB, LR McQuade, KJ Bryant, H Marcal and PP Gray. (2007). Identification of potential pluripotency determinants for human embryonic stem cells following proteomic analysis of human and mouse fibroblast conditioned media. J Proteome Res 6:3796-3807. (Pubitemid 47522768)
70. Prowse AB, LR McQuade, KJ Bryant, DD Van Dyk, BE Tuch and PP Gray. (2005). A proteome analysis of conditioned media from human neonatal fibroblasts used in the maintenance of human embryonic stem cells. Proteomics 5:978-989. (Pubitemid 40469028)
71. Lim JW and A Bodnar. (2002). Proteome analysis of conditioned medium from mouse embryonic fibroblast feeder layers which support the growth of human embryonic stem cells. Proteomics 2:1187-1203.
72. Hollis ER 2nd, P Lu, A Blesch and MH Tuszynski. (2009). IGF-I gene delivery promotes corticospinal neuronal survival but not regeneration after adult CNS injury. Exp Neurol 215:53-59.
73. Nakao Y, H Otani, T Yamamura, R Hattori, M Osako and H Imamura. (2001). Insulin-like growth factor 1 prevents neuronal cell death and paraplegia in the rabbit model of spinal cord ischemia. J Thorac Cardiovasc Surg 122:136-143.
74. Ozdinler PH and JD Macklis. (2006). IGF-I specifically enhances axon outgrowth of corticospinal motor neurons. Nat Neurosci 9:1371-1381. (Pubitemid 44646209)
75. Nakamura M and BS Bregman. (2001). Differences in neurotrophic factor gene expression profiles between neonate and adult rat spinal cord after injury. Exp Neurol 169:407-415. (Pubitemid 32524435)
76. Chen X, Y Li, L Wang, M Katakowski, L Zhang, J Chen, Y Xu, SC Gautam and M Chopp. (2002). Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 22:275-279. (Pubitemid 36142758)
77. Zhou C, C Zhang, S Chi, Y Xu, J Teng, H Wang, Y Song and R Zhao. (2009). Effects of human marrow stromal cells on activation of microglial cells and production of inflammatory factors induced by lipopolysaccharide. Brain Res 1269:23-30.
78. Temple S and X Qian. (1995). bFGF, neurotrophins, and the control or cortical neurogenesis. Neuron 15:249-252.
79. Svendsen CN, MG ter Borg, RJ Armstrong, AE Rosser, S Chandran, T Ostenfeld and MA Caldwell. (1998). A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods 85:141-152. (Pubitemid 29003064)
80. Wright LS, J Li, MA Caldwell, K Wallace, JA Johnson and CN Svendsen. (2003). Gene expression in human neural stem cells: effects of leukemia inhibitory factor. J Neurochem 86:179-195. (Pubitemid 36753859)
81. Erlandsson A, M Enarsson and K Forsberg-Nilsson. (2001). Immature neurons from CNS stem cells proliferate in response to platelet-derived growth factor. J Neurosci 21:3483-3491. (Pubitemid 32422812)
82. Chojnacki A, JJ Kelly, W Hader and S Weiss. (2008). Distinctions between fetal and adult human platelet-derived growth factor-responsive neural precursors. Ann Neurol 64:127-142.
83. Erickson RI, AA Paucar, RL Jackson, K Visnyei and H Kornblum. (2008). Roles of insulin and transferrin in neural progenitor survival and proliferation. J Neurosci Res 86:1884-1894. (Pubitemid 351859437)
84. Schwindt TT, FL Motta, FB Gabriela, GM Cristina, AO Guimaraes, ME Calcagnotto, JB Pesquero and LE Mello. (2009). Effects of FGF-2 and EGF removal on the differentiation of mouse neural precursor cells. An Acad Bras Cienc 81:443-452.
85. Garcez RC, BL Teixeira, S Schmitt Sdos, M Alvarez-Silva and AG Trentin. (2009). Epidermal growth factor (EGF) promotes the in vitro differentiation of neural crest cells to neurons and melanocytes. Cell Mol Neurobiol 29:1087-1091.
86. Okragly AJ and M Haak-Frendscho. (1997). An acidtreatment method for the enhanced detection of GDNF in biological samples. Exp Neurol 145:592-596. (Pubitemid 27314811)